Keros Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Keros Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Keros Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $500K, a 150% increase year-over-year.
  • Keros Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.12M, a 22.9% increase from 2022.
  • Keros Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $913K, a 55.5% increase from 2021.
  • Keros Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $587K, a 25.4% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.12M +$209K +22.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $913K +$326K +55.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $587K +$119K +25.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $468K +$190K +68.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $278K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.